Meeting
2013 ASCO Annual Meeting
How oncologists adhere to evidence-based G-CSF-guidelines to prevent febrile neutropenia: A sample survey in hospitals and practices in Germany.
Authors
Hartmut Link
Deptartment Hematology, Oncology, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany
Hartmut Link , Josef Nietsch , Markus Kerkmann , Petra Angelika Ortner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research
Track
Health Services Research
Sub Track
Outcomes and Quality of Care
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6591)
DOI
10.1200/jco.2013.31.15_suppl.6591
Abstract #
6591
Poster Bd #
17G
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Quality Care Symposium
Assessing the impact of a targeted electronic medical record intervention on growth factor usage in cancer patients.
First Author: Jordan Bernens
Poster
2023 ASCO Genitourinary Cancers Symposium
A retrospective review of primary prophylaxis with granulocyte-colony stimulating factor (G-CSF) for patients with genitourinary malignancies receiving chemotherapy during the COVID-19 pandemic and implications for the future.
First Author: Nely Mercy Diaz Mejia
Poster
2021 ASCO Quality Care Symposium
Association of primary prophylactic (PP) granulocyte-colony stimulating factor (G-CSF) use with chemotherapy dose modifications and relative dose intensity (RDI) among breast cancer patients receiving high-risk regimens for febrile neutropenia (FN).
First Author: Jaime Shaw
Poster
2022 ASCO Quality Care Symposium
An exploratory comparative effectiveness analysis of febrile neutropenia incidence among patients with cancer receiving granulocyte colony stimulating factors.
First Author: Pamala A. Pawloski